Glenmark Pharma Share Price in 2003: Chart, Monthly Trends, & Analysis

How did Glenmark Pharma shares perform in 2003?

Let's find out!

Glenmark Pharma share price in 2003 was ₹16.14 Its price on 1st January 2003 was ₹0.56, and by 31st December 2003 it moved to ₹16.14, giving a positive return of 2% for the year.

Glenmark Pharma Share Open, High, Low, and Close prices for the Year 2003 are as follows:

Open	High	Low	Close
₹0.56	₹64.76	₹0.46	₹16.14
1st Jan 2003	Occured in Dec 2003	Occured in Mar 2003	31st Dec 2003

This page will help you understand how Glenmark Pharma performed in 2003. Let's get started.

For complete insights into Glenmark Pharma’s incredible stock price performance and growth, see: Glenmark Pharma Historical Share Price Data from its IPO to 2025

Table: Glenmark Pharma Share Monthly Close, Low, High Prices for 2003

Month	Glenmark Pharma	Change%	↑High - ↓Low
Jan	₹0.52	-	↑ ₹0.64 ↓ ₹0.5
Feb	₹0.52	-	↑ ₹0.56 ↓ ₹0.48
Mar	₹0.47	-9.7%	↑ ₹0.52 ↓ ₹0.46
Apr	₹0.52	10.6%	↑ ₹9.41 ↓ ₹0.46
May	₹0.57	11.5%	↑ ₹0.59 ↓ ₹0.49
Jun	₹1.34	131%	↑ ₹1.38 ↓ ₹0.56
Jul	₹1.39	3.7%	↑ ₹1.52 ↓ ₹1.23
Aug	₹1.65	18.7%	↑ ₹1.66 ↓ ₹1.31
Sep	₹1.77	7.2%	↑ ₹1.99 ↓ ₹1.48
Oct	₹9.71	448.5%	↑ ₹10.02 ↓ ₹1.55
Nov	₹9.39	-3.3%	↑ ₹34.85 ↓ ₹8.51
Dec	₹16.14	71.8%	↑ ₹64.76 ↓ ₹9.61

Chart: CandleStick and Line Chart Showing Monthly Prices

[Click on line name to show/hide a line]

What if You invested ₹10,000 in Glenmark Pharma in 2003?

In 2003, the opening price of Glenmark Pharma share was ₹0.57. Today, the price stands at ₹1,770, reflecting a growth of 3,10,426.31%. If we applying the same growth to your investment of ₹10,000 then, your investment of ₹10,000 in 2003 would have become ₹3.1 Crore by 2025. This represents a CAGR of 44.12%.

---

You might also like to check: Glenmark Pharma Stock Price in 2002 or Glenmark Pharma Stock Price in 2004

---

References: Stock prices on stockpricearchive.com are gathered from reliable sources only. We take prices from stock exchanges only, majorly from BSE and NSE.

Disclaimer: Information is provided ‘as is’ and solely for informational purposes, not for trading purposes or advice.